Arkolith/Insider Trading/GPCR/Form 4

Lin Xichen

CHIEF SCIENTIFIC OFFICERStructure Therapeutics Inc. (GPCR) · full profile →Form 4 · filed Jun 29, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 25, 2026Option exercise(M)24K$0.34$8K253K
Jun 25, 2026Conversion(C)24K—$0229K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 25, 2026Option exercise(M)24K—$0190K
Jun 25, 2026Conversion(C)8K—$08K
Jun 25, 2026Sell(S)8K$49.08$387K0

Transaction Codes

M
Option exercise / conversion
C
Conversion of a derivative
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001962926-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML